We have located links that may give you full text access.
ENGLISH ABSTRACT
JOURNAL ARTICLE
Immunothérapie dans les carcinomes urothéliaux.
Bulletin du Cancer 2018 December
IMMUNOTHERAPIES FOR UROTHELIAL CARCINOMA: Therapeutic advances in the last 3 decades in bladder cancer were very limited. The 21th century will be more promising with the advent of immunotherapies, with at the top of the list the immune-checkpoint inhibitors. The promising results of the early trials let us hope that these new therapies will soon enroll in the therapeutic landscape of urothelial carcinoma. This article reviews the clinical data of ongoing immunotherapeutic trials (checkpoint inhibitors, vaccine, cytokine) and also the association of the therapies with chemotherapy, antiangiogenics and radiotherapy.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app